Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Olliaro

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|July 17, 1999
Drug development output: what proportion for tropical diseases?P Trouiller, P L Olliaro
Pharmacology & Therapeutics|April 6, 1999
An overview of chemotherapeutic targets for antimalarial drug discoveryP L Olliaro, Y Yuthavong
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 4, 1999
Drug development output from 1975 to 1996: what proportion for tropical diseases?P Trouiller, P L Olliaro
Journal of Postgraduate Medicine|March 30, 2004
Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A reviewP L Olliaro, W R Taylor
Parasitology Today (Personal Ed.)|October 1, 1996
Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malariaN J White, P L Olliaro
Parasitology Today (Personal Ed.)|August 1, 1995
The plasmodium digestive vacuole: metabolic headquarters and choice drug targetP L Olliaro, D E Goldberg
Bulletin of the World Health Organization|January 1, 1995
Status of antimalarial drugs under developmentP L Olliaro, P I Trigg
Parasitology Today (Personal Ed.)|January 1, 1993
Practical progress and new drugs for changing patterns of leishmaniasisP L Olliaro, A D Bryceson
Parasitology Today (Personal Ed.)|January 1, 1993
Antimalarial resistance and health policiesP L Olliaro, P I Trigg
Trends in Parasitology|April 5, 2001
Possible modes of action of the artemisinin-type compoundsP L Olliaro, R K Haynes, B Meunier, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|July 17, 1999
Drug development output: what proportion for tropical diseases?P Trouiller, P L Olliaro
Pharmacology & Therapeutics|April 6, 1999
An overview of chemotherapeutic targets for antimalarial drug discoveryP L Olliaro, Y Yuthavong
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 4, 1999
Drug development output from 1975 to 1996: what proportion for tropical diseases?P Trouiller, P L Olliaro
Journal of Postgraduate Medicine|March 30, 2004
Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A reviewP L Olliaro, W R Taylor
Parasitology Today (Personal Ed.)|October 1, 1996
Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malariaN J White, P L Olliaro
Parasitology Today (Personal Ed.)|August 1, 1995
The plasmodium digestive vacuole: metabolic headquarters and choice drug targetP L Olliaro, D E Goldberg
Bulletin of the World Health Organization|January 1, 1995
Status of antimalarial drugs under developmentP L Olliaro, P I Trigg
Parasitology Today (Personal Ed.)|January 1, 1993
Practical progress and new drugs for changing patterns of leishmaniasisP L Olliaro, A D Bryceson
Parasitology Today (Personal Ed.)|January 1, 1993
Antimalarial resistance and health policiesP L Olliaro, P I Trigg
Trends in Parasitology|April 5, 2001
Possible modes of action of the artemisinin-type compoundsP L Olliaro, R K Haynes, B Meunier, et al.
Pageof 2